App-Quantinova.ai

Hyperuricemia, Urate Lowering Therapy and Kidney Function: A Systemic Review and Meta-Analysis

Gaurav Sharma - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

N/A

Serum Cathepsin S and Cystatin C Relation with Carotid Subclinical Atheromatosis in Rheumatoid Arthritis Patients

Beatriz Tejera Segura - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Elevated Combined Serum Free Light Chains Are Associated With Active Disease In Systemic Lupus Erythematosus

Lakhvir Kaur Assi - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Serum Cystatin C As a Biomarker for Clinical Practice in Patients with Lupus Nephritis

Hua Zhou - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Cyclophosphamide

Comparison of Accuracy of Novel Biomarkers in Predicting Acute Kidney Injury: A Systemic Review

Chu-Ting Chen - American Society of Anesthesiologists (ASA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

Interleukin

Cardiac Dysfunction after Stem Cell Transplantation: Can Peritransplant Cardiac Troponin-I Predict Future Issues?

Seth Joshua Rotz - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Cyclophosphamide

SUBCLINICAL CAROTID ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS: ROLE OF SERUM CATHEPSIN S AND CYSTATIN C

B. Tejera Segura - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

Prednisone

Changes in Urinary Biomarker Levels Can Predict Treatment Responses in Lupus Nephritis

J. Wither - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

GM-CSF

Changes in Urinary Biomarker Levels Can Predict Treatment Responses in Lupus Nephritis

J. Wither - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

GM-CSF

Subclinical Carotid Atherosclerosis in Rheumatoid Arthritis: Role of Serum Cathepsin S and Cystatin C

B. Tejera Segura - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

CYSTATIN C ASSOCIATES WITH DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS INDEPENDENT OF RENAL FUNCTION

S. Nishiyama - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Prednisone

CHANGES IN URINARY BIOMARKER LEVELS CAN PREDICT TREATMENT RESPONSES IN LUPUS NEPHRITIS

J. Wither - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

GM-CSF

Correlation Analysis of Serum Cystatin C and Lipids Levels in Patients with Systemic Lupus Erythematosus

Z. Ye - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

THE IMPORTANCE OF CYSTATIN C AS A PREDICTOR OF ACCELERATED ATHEROSCLEROSIS IN PREMENOPAUSAL NON-DIABETIC PATIENTS WITH RHEUMATOID PATIENTS

I. Holc - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chronic kidney disease

N/A

COMBINED SERUM FREE LIGHT CHAINS ARE ASSOCIATED WITH ACTIVE DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS

L. K. Assi - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

SALIVARY CYSTATIN C AND THE IMBALANCE BETWEEN CYSTEINE PROTEASES AND THEIR INHIBITORS IN CHURG STRAUSS SYNDROME

D. Martini - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anti-neutrophil cytoplasmic antibody-associated vasculitis

Methotrexate

INCREMENTAL VALUE OF CYSTATIN C BEYOND CONVENTIONAL MARKERS OF RENAL FUNCTION FOR PREDICTING CLINICAL RESPONSE IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: THE BIOCRT STUDY

Neal Chatterjee - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left bundle branch block

Vista

EFFICACY OF HIGH-DOSE STATIN FOR PREVENTION OF CONTRAST- INDUCED NEPHROPATHY (CIN) IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS

Anene Ukaigwe - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Contrast-induced Acute Kidney Injury

Atorvastatin

ELEVATED CYSTATIN C IS A SIGNIFICANT INDEPENDENT PREDICTOR OF MORTALITY AND CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH PERIPHERAL ARTERY DISEASE

Gwang Sil Kim - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Contrast-induced Acute Kidney Injury

Methadone hydrochloride

CYSTATIN C AS A PREDICTOR OF ALL-CAUSE AND CARDIOVASCULAR MORTALITIES IN PATIENTS WITHOUT CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

Harumi Katoh - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

N/A

Filters

169 Abstracts